Non-Alcoholic Fatty Liver Disease Latest Advances

The role of NEDD4L in metabolic dysfunction-associated fatty liver disease (MAFLD) by regulating ferroptosis via deubiquitinating the TGF-β receptor TβRII.

Journal: Biochemistry and cell biology = Biochimie et biologie cellulaire

Published: December 15, 2025

Quantification of Liver Stiffness Using Magnetic Resonance Elastography in Comparison with Transient Elastography and Noninvasive Fibrosis Score in Fatty Liver.

Journal: The Journal of the Association of Physicians of India

Published: December 14, 2025

MASLD-A Gateway for ASCVD: A Call for Early Intervention and Multidisciplinary Care.

Journal: The Journal of the Association of Physicians of India

Published: December 14, 2025

Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m6A modification.

Journal: Gut microbes

Published: December 12, 2025

Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese Population.

Journal: Research square

Published: December 11, 2025

Effects of Chronic Elevation in Plasma Membrane Cholesterol on the Function of Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) and Organic Cation Transporter 1 (OCT1).

Journal: Livers

Published: December 11, 2025

Corrigendum to "Structural characterisation of Cistanche tubulosa polysaccharides and their effects against non-alcoholic steatohepatitis via gut microbiota regulation" [Carbohydrate Polymers 371 (2026) 124495].

Journal: Carbohydrate polymers

Published: December 10, 2025

Met-ALD and ALD- Does Differentiating These Impact Management and Clinical Outcomes?

Journal: Current hepatology reports

Published: December 10, 2025

Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Journal: JAAPA : official journal of the American Academy of Physician Assistants

Published: December 10, 2025

Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis.

Journal: Science advances

Published: December 10, 2025

Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide.

Journal: Current medical research and opinion

Published: December 09, 2025

Corrigendum to "Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways" [Biomed. Pharmacother. 141 (2021) 1-12/111874].

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: December 09, 2025

Filters

The role of NEDD4L in metabolic dysfunction-associated fatty liver disease (MAFLD) by regulating ferroptosis via deubiquitinating the TGF-β receptor TβRII.

The role of NEDD4L in metabolic dysfunction-associated fatty liver disease (MAFLD) by regulating ferroptosis via deubiquitinating the TGF-β receptor TβRII.

Quantification of Liver Stiffness Using Magnetic Resonance Elastography in Comparison with Transient Elastography and Noninvasive Fibrosis Score in Fatty Liver.

Quantification of Liver Stiffness Using Magnetic Resonance Elastography in Comparison with Transient Elastography and Noninvasive Fibrosis Score in Fatty Liver.

MASLD-A Gateway for ASCVD: A Call for Early Intervention and Multidisciplinary Care.

MASLD-A Gateway for ASCVD: A Call for Early Intervention and Multidisciplinary Care.

Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m6A modification.

Helicobacter pylori infection aggravates hepatic steatosis by lactylation-driven WTAP-mediated m6A modification.

Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese Population.

Predictors of Metabolic Dysfunction-Associated Steatotic Liver Diseases (MALSD) in Vietnamese Population.

Effects of Chronic Elevation in Plasma Membrane Cholesterol on the Function of Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) and Organic Cation Transporter 1 (OCT1).

Effects of Chronic Elevation in Plasma Membrane Cholesterol on the Function of Human Na+/Taurocholate Cotransporting Polypeptide (NTCP) and Organic Cation Transporter 1 (OCT1).

Corrigendum to "Structural characterisation of Cistanche tubulosa polysaccharides and their effects against non-alcoholic steatohepatitis via gut microbiota regulation" [Carbohydrate Polymers 371 (2026) 124495].

Corrigendum to "Structural characterisation of Cistanche tubulosa polysaccharides and their effects against non-alcoholic steatohepatitis via gut microbiota regulation" [Carbohydrate Polymers 371 (2026) 124495].

Met-ALD and ALD- Does Differentiating These Impact Management and Clinical Outcomes?

Met-ALD and ALD- Does Differentiating These Impact Management and Clinical Outcomes?

Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Screening and management of metabolic dysfunction-associated steatotic liver disease (MASLD).

Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis.

Decoding the CHI3L1/IL-13Rα2 signaling nexus in MASH-fibrosis pathogenesis.

Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide.

Changes in liver enzymes and cardiometabolic markers in individuals with obesity and metabolic-dysfunction-associated steatohepatitis treated with semaglutide.

Corrigendum to "Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways" [Biomed. Pharmacother. 141 (2021) 1-12/111874].

Corrigendum to "Bicyclol ameliorates nonalcoholic fatty liver disease in mice via inhibiting MAPKs and NF-κB signaling pathways" [Biomed. Pharmacother. 141 (2021) 1-12/111874].